The present invention provides a compound of Formula (I) (represented as tautomers Ia and Ib) or the pharmaceutically acceptable salts thereof, which are KDM5 inhibitors.
The present invention provides a compound of Formula (I) (represented as tautomers Ia and Ib) or the pharmaceutically acceptable salts thereof, which are KDM5 inhibitors.
本发明提供了一种式(I)化合物(以同系物 Ia 和 Ib 表示)或其药学上可接受的盐,它们是 KDM5 抑制剂。
KDM5 INHIBITORS
申请人:MANSOOR UMAR Faruk
公开号:US20200048258A1
公开(公告)日:2020-02-13
The present invention provides a compound of Formula (I) (represented as tautomers Ia and Ib) or the pharmaceutically acceptable salts thereof, which are KDM5 inhibitors.